Table 1.

Laboratory findings

Blood cell count			Biochemistry			Serological test
WBC	4200	/μL	TP	7.3	g/dL	IgG	1431	mg/dL	ANA	Negative
Neutrophil	57.1	%	Alb	4.2	g/dL	IgA	202	mg/dL	AMA	Negative
Lymphocyte	28.5	%	T-bil	1.0	mg/dL	IgM	92	mg/dL	AMA-M2	Negative
Monocyte	8.6	%	AST	631	U/L	IgM HAVAb	Negative		ACA	Negative
Eosinophil	4.6	%	ALT	1,008	U/L	IgM HBcAb	Negative		LKM-1Ab	Negative
Basophil	1.2	%	LDH	444	U/L	HBsAg	Negative
RBC	480 × 104	/μL	ALP	211	U/L	HBsAb	Negative		DLST
MCV	95.2	fl	γ-GTP	194	U/L	HBcAb	Negative		Amlodipine	Negative
MCH	30	Pg	ChE	390	U/L	HCV RNA	6.2	log IU/mL
MCHC	31.5	%	BUN	14.7	mg/dL	HCV genotype	2A
Hb	14.4	g/dL	Cre	1.0	mg/dL	IgA HEVAb	Negative
Hct	45.7	%	Na	141	mmol/L	EBV VCA IgG	Positive
Plt	26.7 × 104	/μL	K	4	mmol/L	EBV VCA IgM	Negative
			Cl	106	mmol/L	CMV IgG	Positive
Coagulation			AFP	4.2	ng/mL	CMV IgM	Negative
PT%	102	%	PIVKA-II	18	mAU/mL	M2BPGi	2.7	COI

WBC white blood cell, RBC red blood cell, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, Hb hemoglobin, Hct hematocrit, Plt platelets, PT prothorombin time, TP total protein, Alb albumin, T-bil total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP γ-glutamyl transpeptidase, ChE cholinesterase, BUN blood urea nitrogen, Cre creatinine, Na natrium, K kalium, Cl chloride, AFP α-fetoprotein, PIVKA-II protein induced by vitamin K absence or antagonist-II, IgG immunoglobulin G, IgA immunoglobulin A, IgM immunoglobulin M, HAV hepatitis A virus, Ab antibody, HBc hepatitis B core, HBs hepatitis B surface, Ag antigen, HCV hepatitis C virus, HEV hepatitis E virus, EBV VCA Epstein-Barr virus capsid antigen, CMV cytomegalovirus, M2BPGi mac2 binding protein glucosylation isomer, ANA anti-nuclear antibody, AMA anti-mitochondrial antibody, AMA-M2 anti-mitochondrial M2 antibody, ACA anti-centromere antibody, LKM-1 liver/kidney microsome 1, DLST drug-induced lymphocyte stimulation test